603168 logo

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Stock Price

SHSE:603168 Community·CN¥2.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603168 Share Price Performance

CN¥6.81
0.50 (7.92%)
CN¥6.81
0.50 (7.92%)
Price CN¥6.81

603168 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with minimal risk.

1 Risk
0 Rewards

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Key Details

CN¥475.2m

Revenue

CN¥236.0m

Cost of Revenue

CN¥239.2m

Gross Profit

CN¥304.3m

Other Expenses

-CN¥65.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 15, 2026
-0.17
50.34%
-13.69%
17.3%
View Full Analysis

About 603168

Founded
2000
Employees
1328
CEO
Hong Li Lin
WebsiteView website
www.zjspas.com

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.

Recent 603168 News & Updates

Recent updates

No updates